Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › JAK kinase inhibitor compounds for treatment of respiratory disease

JAK kinase inhibitor compounds for treatment of respiratory disease

US Patent 10913740 · Granted Feb 9, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted benzenecarboxamides as IL-17A modulators2025
Substituted benzenecarboxamides as IL-17A modulators2025
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amin2025
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amin2025
Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl2025
1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-A]2025
IL-17 ligands and uses thereof2025
IL-17 ligands and uses thereof2025
Pyrimidine compound as JAK kinase inhibitor2024
Pyrimidine compound as JAK kinase inhibitor2024
Vasopressin receptor antagonists and products and methods related thereto2024
JAK inhibitors containing a 4-membered heterocyclic amide2024